Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H24N2O2 |
Molecular Weight | 312.4061 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CN(CC(=O)N1CCC3=C2C=CC=C3)C(=O)C4CCCCC4
InChI
InChIKey=FSVJFNAIGNNGKK-KRWDZBQOSA-N
InChI=1S/C19H24N2O2/c22-18-13-20(19(23)15-7-2-1-3-8-15)12-17-16-9-5-4-6-14(16)10-11-21(17)18/h4-6,9,15,17H,1-3,7-8,10-13H2/t17-/m0/s1
Molecular Formula | C19H24N2O2 |
Molecular Weight | 312.4061 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Praziquantel, (-)- is oxopyrazinoisoquinoline derivative and a levorotated isomer of Praziquantel patented by Merck Patent G.m.b.H. as anthelmintics agent. In rabbits infested with S. japonicum, the therapeutic effect of Praziquantel, (-)-was greater than that of dl-praziquantel as rated by the number of the worms in tissues and by liver damage. Histopathological examination showed that liver egg granulomas in the levo-praziquantel group were fewer in no. and smaller in size and were predominantly composed of Pseudotubercles instead of eosinophilic abscesses. Levo-praziquantel is therapeutically superior to praziquantel, while dextro-praziquantel is almost ineffective.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24982093
mice: 100, 200, or 400 mg/kg
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:19:42 GMT 2023
by
admin
on
Sat Dec 16 08:19:42 GMT 2023
|
Record UNII |
WF15T5925V
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
584317
Created by
admin on Sat Dec 16 08:19:43 GMT 2023 , Edited by admin on Sat Dec 16 08:19:43 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
WF15T5925V
Created by
admin on Sat Dec 16 08:19:43 GMT 2023 , Edited by admin on Sat Dec 16 08:19:43 GMT 2023
|
PRIMARY | |||
|
445900
Created by
admin on Sat Dec 16 08:19:43 GMT 2023 , Edited by admin on Sat Dec 16 08:19:43 GMT 2023
|
PRIMARY | |||
|
DB11749
Created by
admin on Sat Dec 16 08:19:43 GMT 2023 , Edited by admin on Sat Dec 16 08:19:43 GMT 2023
|
PRIMARY | |||
|
DTXSID80904739
Created by
admin on Sat Dec 16 08:19:43 GMT 2023 , Edited by admin on Sat Dec 16 08:19:43 GMT 2023
|
PRIMARY | |||
|
57452-98-9
Created by
admin on Sat Dec 16 08:19:43 GMT 2023 , Edited by admin on Sat Dec 16 08:19:43 GMT 2023
|
PRIMARY | |||
|
C171715
Created by
admin on Sat Dec 16 08:19:43 GMT 2023 , Edited by admin on Sat Dec 16 08:19:43 GMT 2023
|
PRIMARY | |||
|
300000010220
Created by
admin on Sat Dec 16 08:19:43 GMT 2023 , Edited by admin on Sat Dec 16 08:19:43 GMT 2023
|
PRIMARY | |||
|
11106
Created by
admin on Sat Dec 16 08:19:43 GMT 2023 , Edited by admin on Sat Dec 16 08:19:43 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
RACEMATE -> ENANTIOMER |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |